Metformin
Metformin — patient guide
Prescribed for: Type 2 diabetes (first-line oral therapy) · Polycystic ovary syndrome (off-label — insulin resistance, ovulation) · Prediabetes / impaired glucose tolerance (off-label — high cardiometabolic risk) · Gestational diabetes (off-label — alternative or adjunct to insulin)
Metformin is the first-line oral medicine for type 2 diabetes in Australia. It works mainly by reducing the amount of sugar your liver makes overnight and helping your muscles use insulin more efficiently. It doesn't cause low blood sugars on its own and it doesn't cause weight gain.
It's also used off-label for polycystic ovary syndrome, prediabetes, and selected gestational diabetes cases — with good evidence in each. Off-label means the TGA hasn't formally listed it for that purpose, not that it doesn't work.
Most stomach side effects settle in 2-3 weeks if you titrate slowly and take it with food. The two things to watch for long-term are vitamin B12 (check annually after 12 months) and pausing the tablet during vomiting, severe illness, before CT scans with contrast, and before major surgery. Lifestyle changes work alongside the medicine and can sometimes lower or end the need for it.
This page covers metformin in all the forms it comes in — Diabex, Diaformin, the XR versions, and the combination tablets that include metformin plus another medicine. If your tablet name is on the list below, this is your page.
You’ve probably arrived here for one of three reasons. You’ve just been told you have type 2 diabetes and the word feels heavier than the doctor seemed to think it was. You have PCOS and your GP added metformin to the plan with two sentences of explanation and you’re not sure why you’re on a diabetes medicine when you don’t have diabetes. Or your last bloods came back in the “prediabetes” range and you’re trying to work out whether starting a tablet is the right move or whether you’ve got time to try the lifestyle path first.
All three are reasonable places to be standing. Let me give you the longer version of each conversation.
Find your medicine
| Generic name | Common brand names | Strengths | How often |
|---|---|---|---|
| Metformin (immediate release) | Diabex, Diaformin, Glucohexal, Glucophage, generics | 500 / 850 / 1000 mg | 2-3 times daily with meals |
| Metformin (modified release / XR) | Diabex XR, Diaformin XR, generics | 500 / 1000 mg | Once daily with the evening meal |
IR vs XR. They are the same medicine, dosed differently. IR (immediate release) hits faster, wears off faster, and is taken 2-3 times a day with food. XR (modified release) absorbs gradually over the day and is taken once with the evening meal. XR causes fewer stomach side effects for most people. The standard approach is to start with IR, titrate slowly, and switch to XR mg-for-mg if the stomach side effects don’t settle within 2-3 weeks.
Closely related families worth knowing exist — SGLT2 inhibitors (names end in -flozin), GLP-1 receptor agonists (Ozempic, Trulicity, Mounjaro), DPP-4 inhibitors (names end in -gliptin), and the older sulfonylureas (gliclazide, glibenclamide). Each of these has its own page or will soon. Many people end up on metformin plus one of these — often as a combination tablet (see the list below).
What it treats
Metformin is the first-line oral medicine for type 2 diabetes per the RACGP T2DM guidelines, eTG, and NICE NG28. That’s the on-label use — what the TGA has formally signed off on.
It’s also used off-label, with real evidence, for three other situations:
-
Polycystic ovary syndrome. Insulin resistance is part of the picture in most women with PCOS, and metformin can help with cycle regularity, ovulation, and the metabolic side. The 2020 Cochrane review supports its use; the RACGP Red Book PCOS module accepts it as part of an integrated plan. Important nuance: metformin is adjunct, not the headline. Lifestyle change and (where appropriate) the combined oral contraceptive pill remain the first-line considerations for menstrual regulation. Metformin earns its place in the metabolic / insulin-resistance / ovulation conversations.
-
Prediabetes. The Diabetes Prevention Program (NEJM 2002) — one of the most-cited diabetes prevention trials ever run — showed metformin reduced progression from prediabetes to type 2 diabetes by about 31% over 2.8 years. The lifestyle arm of the same trial reduced it by about 58%. Lifestyle wins, and that comparison matters. Metformin is a real second-line option, particularly if BMI is 35 or above or if hyperglycaemia is progressing despite genuine effort.
-
Gestational diabetes. The MiG trial (NEJM 2008) showed metformin non-inferior to insulin for many gestational diabetes cases. RANZCOG and ADIPS accept it as a reasonable option in selected cases. Decision is shared with the obstetric team.
Off-label in Australia means the TGA hasn’t formally listed metformin for these uses. It does not mean the evidence is missing — in PCOS, prediabetes, and GDM the evidence is real. Off-label use is normal in medicine and well-recognised by RACGP. I’ll discuss the off-label status with you and document the decision, and you should hold the choice with full information.
The basics
- Take it with food, every time. The stomach side effects are real if you take it on an empty stomach. With a meal, most settle in 2-3 weeks.
- Titrate slowly. Standard start is 500 mg with dinner for week one, then 500 mg twice daily with breakfast and dinner. Faster ramp-ups produce more side effects, not better glucose control.
- Pause it when you’re sick, before scans with contrast, and before surgery. Sick day rules below — they matter.
- Get your B12 checked annually after 12 months. Long-term metformin reduces B12 absorption in about 10-30% of users.
- Message me before you start anything new — supplements, herbs, big diet changes. Some interact. Berberine especially is worth a conversation, not a solo experiment.
Everything else — mechanism, side effects in detail, the integrative angle, the conversation about earning a lower dose — is below.
What to expect in the first month
Week 1
- Start 500 mg with dinner. Take it in the middle of the meal, not before.
- You may notice loose stools, mild nausea, or a metallic taste. Expected. Most settle.
- You probably won’t “feel” anything different from a blood-sugar point of view. That’s normal — metformin doesn’t drop sugars dramatically the way insulin does.
Week 2
- Add 500 mg with breakfast (now twice daily).
- Stomach symptoms often peak around now. Take each dose mid-meal. Push fluids.
Weeks 3-4
- If stomach symptoms have settled, we continue titrating toward the target dose (commonly 1 g twice daily for T2DM; lower for PCOS / prediabetes).
- If stomach symptoms haven’t settled, we switch to the XR version mg-for-mg.
- First HbA1c recheck is usually around 3 months — that’s when we see the glucose effect.
Sick day rules — when to pause
If you have any of these for more than a few hours, pause the metformin and message us:
- Vomiting
- Severe diarrhoea
- Fever where you can’t keep fluids down
- Heavy sweating with poor fluid intake
- Any acute serious illness — chest infection requiring hospital, suspected sepsis, severe pain
Also pause:
- 24-48 hours before and after a CT scan with iodinated contrast if your eGFR is below 60
- 24-48 hours before major surgery (anaesthetist usually confirms)
Restart once you’re eating, drinking, and well — usually 24-48 hours. If you’re not sure, message.
The reason: metformin is cleared by the kidneys. When you’re dehydrated or acutely unwell, kidney function drops temporarily, and metformin can accumulate. The serious version of that accumulation is called lactic acidosis. Rare in modern practice when sick day rules are followed — the Salpeter Cochrane 2010 review found no excess risk in people with normal kidney function — but worth the pause-when-you’re-sick discipline.
Tap any section below to expand the detail.
How does it work?
Metformin’s main effect is on the liver. Overnight, when you’re not eating, your liver produces glucose to keep your fasting blood sugar steady — a process called gluconeogenesis. In type 2 diabetes (and in insulin resistance more broadly), that overnight production is too high. Metformin reduces it.
The mechanism handle worth knowing: metformin activates an enzyme called AMP-activated protein kinase (AMPK) — a cellular fuel sensor that tells the body “energy is low, switch from making glucose to using it.” That same AMPK pathway also improves insulin sensitivity in muscle, which is the second main effect.
Three useful properties fall out of that mechanism:
- It doesn’t cause low blood sugars on its own (because it doesn’t push insulin — it works on the liver and muscle response).
- It doesn’t cause weight gain (and often produces modest weight loss).
- The cardiovascular protection signal in the original UKPDS 34 trial (Lancet 1998) — a 39% reduction in heart attacks over 10 years in overweight T2DM patients — is the headline that put metformin in the first-line slot and has kept it there for nearly three decades.
The mitochondrial-AMPK angle is also why metformin keeps showing up in longevity research (TAME trial, ongoing). Interesting research direction. Not yet a recommendation for healthy adults.
Side effects in detail
Common (usually settle in 2-3 weeks)
- Diarrhoea, loose stools, nausea, metallic taste. Around 25% of people get one or more in the first 2-3 weeks. Two fixes that work in combination: always take with food, and titrate slowly. If symptoms persist beyond 2-3 weeks despite slow titration, switching to the XR (modified release) version mg-for-mg often resolves it.
- Reduced appetite, mild weight loss. Often welcome. Sometimes a sign the dose is at the upper end of what your bowel tolerates.
Less common but worth watching for
- Vitamin B12 deficiency with long-term use (12+ months). 10-30% prevalence per the DPPOS data (Aroda et al., JCEM 2016). Annual measurement after the first year is the standard plan. Symptoms — tingling in feet, numbness, fatigue, memory issues — can mimic diabetic nerve damage. Easy to mis-attribute if no-one checks. Supplementation works: 500-1000 mcg oral cyanocobalamin daily is usually enough; IM hydroxocobalamin if absorption is impaired.
- Persistent stomach upset that doesn’t settle after the XR switch. A real “this medicine isn’t for me” signal. We move to a different first-line option.
Rare but serious — go to ED
- Lactic acidosis. Sudden severe muscle pain, deep rapid breathing, drowsiness, severe abdominal pain, persistent vomiting — particularly if you’ve been unwell or dehydrated and haven’t paused the metformin. Rare in modern practice when sick day rules are followed; the Salpeter Cochrane 2010 review found no excess risk in people with normal kidney function. The risk concentrates in three situations: acute kidney injury with the medicine still on board, severe sepsis, and iodinated-contrast exposure in chronic kidney disease without a pause. Stop the medicine and get to ED.
- Severe abdominal pain without a clear cause. Worth mentioning to us promptly.
Drugs, food, and alcohol
Tell me or your pharmacist before combining with:
- Iodinated contrast (CT scan dye). Pause 24-48 hours before and after if eGFR is below 60. MRI contrast (gadolinium) is usually fine and doesn’t need a pause.
- Cimetidine (an older heartburn medicine — now mostly replaced by famotidine). Mildly reduces metformin clearance. Usually OK; we just monitor.
- Alcohol. Light to moderate amounts are usually fine. Heavy or binge drinking amplifies the lactic acidosis risk meaningfully — that’s the main interaction worth knowing.
- Other diabetes medicines. Combinations are standard practice — metformin pairs well with SGLT2 inhibitors, GLP-1 receptor agonists, DPP-4 inhibitors. Most of those combinations now come as a single tablet (see the list below). The combination to be cautious with is metformin + sulfonylurea (gliclazide, glibenclamide) — risk of low blood sugars goes up, particularly in older adults and those with kidney disease.
- Topiramate (for migraine or weight management — Topamax, Qsymia). Can rarely cause metabolic acidosis on its own; combining with metformin warrants monitoring.
Food. No specific restrictions. Always take metformin during a meal, not before or after. Carbohydrate quality matters more for your overall picture than any single food rule — see the integrative section below.
Alcohol. Light to moderate amounts in the context of well-controlled diabetes are usually fine. Heavy or binge drinking is the real interaction — the lactic acidosis risk is amplified, and alcohol disrupts glucose control independently.
Generic substitution at the pharmacy. Generic metformin is bioequivalent to the branded versions. Diabex, Diaformin, Glucohexal, Glucophage, and unbranded generics all work the same. If your pharmacist offers a cheaper generic, that’s fine. The one switch worth flagging: IR to XR (or vice versa) is not a like-for-like swap from a side-effect point of view — same dose, different release profile. If your pharmacist offers that swap, confirm with us first.
Monitoring — what blood tests and when
- Baseline before starting: eGFR (kidney function), HbA1c, fasting glucose, liver function, B12.
- HbA1c every 3 months until on a stable dose with a stable result, then every 6 months.
- eGFR annually (or sooner if you have CKD, are on combinations of other kidney-relevant medicines, or have been acutely unwell).
- Vitamin B12 annually after the first 12 months on metformin. Earlier if you have symptoms (tingling, numbness, fatigue, memory changes).
- Dose adjustment thresholds (per Inzucchi et al., JAMA 2014):
- eGFR ≥45: full dose, no restriction
- eGFR 30-45: maximum 1 g/day; do not start new
- eGFR less than 30: contraindicated, stop
Message us if you: start a new medicine (including over-the-counter or supplements), get a gastro illness, start a new diet, plan a CT scan with contrast or major surgery, or notice new tingling / numbness / persistent fatigue.
Stopping or pausing
Don’t stop on your own without talking to me first — but pausing for sick days is part of normal use, not stopping.
- Sick day pauses (above) — 24-48 hours during gastro, severe illness, contrast scans, or major surgery. Resume when eating and drinking and well.
- If side effects are the issue, we usually adjust the formulation (IR → XR), the dose, or the timing rather than stop the medicine entirely. There are also alternative diabetes medicines if metformin genuinely doesn’t suit.
- If your situation changes — substantial weight loss, big improvements in HbA1c on lifestyle, prediabetes resolved — the dose may genuinely come down. Done together, with monitoring.
- Before surgery, your anaesthetist or surgical team usually asks you to hold a dose. Follow their instructions; tell them you’re on metformin.
Pregnancy and breastfeeding
Metformin in pregnancy is a shared decision with your obstetric team.
- Pre-conception (PCOS): metformin is sometimes continued through early pregnancy if it was being used for PCOS-related insulin resistance and conception challenges. The decision is individualised.
- Gestational diabetes: metformin is used off-label in selected cases per the MiG trial (NEJM 2008) and the RANZCOG/ADIPS consensus. About 46% of women in MiG still required supplemental insulin. Long-term offspring follow-up data continues to evolve — a real and honest gap, not a hidden one.
- TGA pregnancy category C. Discuss with us and with your obstetric team.
Breastfeeding. Metformin passes into breast milk in small amounts and is generally considered compatible with breastfeeding. Monitor the infant for any unusual symptoms; discuss case-by-case.
If you’re on a combination tablet
Many people on metformin are actually on a combination tablet — metformin plus a second diabetes medicine in one pill, which reduces the number of tablets per day and often the PBS cost.
Metformin + DPP-4 inhibitor (works on a different pathway — the incretin system):
- Janumet / Janumet XR = sitagliptin + metformin
- Galvumet = vildagliptin + metformin
- Komboglyze = saxagliptin + metformin
- Trajentamet = linagliptin + metformin
Metformin + SGLT2 inhibitor (helps the kidneys excrete glucose, has heart and kidney protection benefits):
- Xigduo / Xigduo XR = dapagliflozin + metformin
- Synjardy / Synjardy XR = empagliflozin + metformin
- Segluromet = ertugliflozin + metformin
Metformin + sulfonylurea (older, used less now due to hypoglycaemia and weight gain from the sulfonylurea component):
- Glucovance = metformin + glibenclamide
Withdrawn: Avandamet (rosiglitazone + metformin) is no longer available in Australia due to safety concerns with the rosiglitazone component.
Everything on this page applies to the metformin portion of your combination tablet. The other drug has its own side effects, monitoring requirements, and sick day rules — ask me, and I’ll get you the relevant page when it’s ready.
Cost
Metformin is on the PBS and is one of the cheapest diabetes medicines available. From 1 January 2026, the PBS co-payment ceiling is:
- General patient: up to $25.00 per script
- Concession card holder: up to $7.70 per script
Generic metformin often costs less than the co-payment threshold (“under-co-payment” pricing) — you may pay $5-15 per script for plain IR metformin in many pharmacies. XR formulations and combination tablets typically cost more per script. Confirm pricing with your pharmacist — they can show you the cheapest equivalent.
(MBS / PBS items verified 2026-05-24 via WebSearch — workspace egress to mbsonline.gov.au + pbs.gov.au still blocked; spot-check confirms current.)
This is not a cop-out — it’s the reason the consult exists. You are biochemically unique. Anything I write here may apply to you completely, in part, or not at all, and there is no honest way to know in advance. Some people are allergic to peanuts; your biochemistry has its own particulars, and uncovering them is its own work — done by experimenting on yourself, with informed starting points. Everything on this page is general in nature for exactly that reason. The specific version of any of this is a conversation, not an article.
The integrative view
Most of the patients I see want to do everything they reasonably can alongside the medicine — and metformin is one of the medicines where that posture pays off the most. The reason is in the DPP trial numbers from earlier: lifestyle change reduced progression to T2DM by 58%, metformin by 31%. Lifestyle is the lever metformin amplifies, not replaces. Stack them together and the picture gets meaningfully better than either one alone.
Two principles I work from. First: metformin works, and it’s one of the best-evidenced medicines in modern medicine. Lifestyle changes also work — often more powerfully on the underlying problem. Combined, they outperform either alone. Second: this is not a permanent sentence. For prediabetes, PCOS, and earlier-stage T2DM, your dose can sometimes come down — occasionally off — if you genuinely change the underlying terrain.
Strong evidence — these reliably help glucose control
These are interventions where the data is solid enough that I’d discuss them with any patient on metformin. The effect sizes below are approximations from clinical trials; your individual response will vary.
- DASH-style or Mediterranean-style eating pattern. Vegetables, fruit, legumes, whole grains, oily fish, olive oil, nuts. Both patterns have multi-trial data showing improvements in HbA1c, blood pressure, and cardiovascular outcomes. The Mediterranean pattern in particular has strong data in metabolic syndrome.
- Low-glycaemic-index / carbohydrate-quality approach. Less about cutting carbs entirely and more about choosing the slower-absorbing versions — legumes, oats, intact whole grains, vegetables — over the fast ones (white bread, sugary drinks, refined cereals). HbA1c reductions of 0.3-0.5% are typical with sustained change.
- Resistance training. 2-3 sessions per week. Improves insulin sensitivity per minute of training more than aerobic exercise does — a useful fact for people who say “I don’t have time for an hour of cardio.” 20 minutes of weights twice a week meaningfully shifts the picture.
- Aerobic exercise. 150 minutes per week of brisk walking, cycling, or equivalent. Synergistic with resistance training.
- Time-restricted eating / intermittent fasting. Emerging evidence is encouraging — an 8-10 hour eating window appears to improve glycaemic control and weight in T2DM without complex tracking. Cochrane and NICE positions are evolving. Works synergistically with metformin. If you choose to experiment, start by closing your kitchen 3 hours before bed. See how you respond.
- Treating sleep apnoea if present. Sleep deprivation and untreated OSA worsen insulin resistance measurably. Snoring + daytime tiredness + observed pauses in breathing → worth a sleep study.
Moderate evidence — likely helpful
- Magnesium-rich foods (leafy greens, nuts, seeds, legumes, dark chocolate). Adequate magnesium supports insulin signalling. Food first; supplementation only if there’s a specific reason and a measured deficit.
- Vitamin D adequacy. Target 75-100 nmol/L. Independent association with glycaemic control. Check level; supplement if low.
- Zinc adequacy. Supports glucose handling. Food first.
- Stress reduction practices — slow breathing (~6 breaths/minute), meditation, yoga. Modest direct glucose effect; bigger indirect effect via cortisol patterns and food choices.
Limited or emerging evidence
- Cinnamon, fenugreek, bitter melon, gymnema. Modest evidence, considerable individual variation. If they’re already part of your eating culture, that’s fine. Supplement form is low-confidence for me — I won’t talk you out of it but wouldn’t recommend buying it.
- Omega-3 (fish oil), 1-3 g EPA/DHA daily. Cardiovascular protection more than glucose effect. The high-EPA REDUCE-IT trial showed benefit in high-triglyceride patients.
- CoQ10, L-carnitine. Speculative mitochondrial / ageing support. No robust RCTs in T2DM. Not a recommendation I’d make on the data; not actively harmful in typical doses.
Specific to being on metformin
- Berberine 500 mg three times daily. Activates the same AMPK pathway metformin uses, with RCT evidence in PCOS, lipids, and glycaemic control. Not a substitute for metformin in established T2DM — the outcome data isn’t comparable. Can complement in PCOS and prediabetes situations. Two cautions: berberine inhibits CYP3A4 and interacts with several common medicines (including some statins and blood thinners), and it has its own stomach side effects that can stack with metformin’s. Not safe in pregnancy. If you’re considering it, that’s the conversation we have in the consult — not a solo experiment.
- Vitamin B12. Covered above — annual measurement after the first year. Supplementation if low.
- Hydration. Stay genuinely hydrated. Metformin plus dehydration is the situation we’re trying to avoid.
Earning a lower dose
This is the conversation most people on metformin are quietly hoping to have. Three scenarios where it’s realistic:
- Type 2 diabetes (earlier stages). Substantial sustained lifestyle change — particularly meaningful weight loss, consistent resistance training, sleep apnoea treatment — can bring HbA1c down enough to reduce the dose. Sometimes off entirely. We do this with regular monitoring, not on your own. The exception is established diabetes with significant duration or complications; there the medicine is doing structural protection beyond a glucose number, and we usually keep it going.
- PCOS. As cycles regulate and insulin resistance improves with lifestyle and time, metformin often becomes unnecessary. Many women come off it within 1-2 years of good metabolic work.
- Prediabetes. The explicit goal is dose-reduction-to-stop as the underlying picture normalises. If we started metformin because lifestyle alone wasn’t enough at the start, that doesn’t mean it’s permanent.
You always have a choice. Each choice has a consequence. The medicine is one lever; the terrain underneath it is another. The two work together.
Track these between now and your next visit
- Home blood glucose readings if you have a meter — fasting and 2-hours-post-meal, a few times a week. Bring the log.
- Any new symptoms — stomach upset, tingling in feet, persistent fatigue, taste changes. Note when they started and how often.
- Anything new you’ve started — supplements, herbs, big diet changes, new medicines from another doctor.
- Sick days, contrast scans, or surgery since the last visit, and whether you paused the metformin.
- Your weight, your exercise routine, your sleep pattern — short notes, not a spreadsheet. The trajectory matters more than the precision.
Bring the list to your review appointment.
This is general information, not personal medical advice. Every patient is different. Decisions about your medicines — which one, what dose, when to stop, what to combine with — are made with the doctor who prescribed them. If anything on this page appears to contradict advice from your treating doctor, follow your doctor; they have context about your situation that this page cannot.
Reading this page does not establish a doctor-patient relationship with Dr Hoebing Lo. If you are not a current patient, please discuss your medicines with your own GP, specialist, or pharmacist.
About the integrative content. The lifestyle, dietary, and complementary recommendations on this page summarise current published research. Effect sizes are approximations from clinical studies — your individual response will vary, and real-world results are commonly smaller than trial results because day-to-day life differs from study conditions. Supplements and herbal products are not interchangeable with prescribed medication and can interact with it. Talk to your doctor and pharmacist before starting any new supplement, herbal product, or significant change in diet.
Off-label use. Some uses of metformin discussed on this page — for polycystic ovary syndrome, prediabetes, and gestational diabetes — are off-label in Australia. Off-label means the TGA has not formally listed the medicine for that purpose; it does not mean the evidence is absent. The evidence base for off-label use varies by indication and is referenced inline. Off-label use is normal in medicine and well-recognised by the RACGP. The decision is shared between you and your prescriber, with the off-label status documented.
Currency. This page reflects clinical practice as of the last-reviewed date. Medicine evolves; specific details may date between reviews. Pricing shown is indicative; confirm with your pharmacist.
No commercial relationships. Dr Hoebing Lo has no financial or commercial relationship with the manufacturer of any medicine, brand, or supplement mentioned on this page.
Emergencies. If you have severe abdominal pain with rapid deep breathing, drowsiness, persistent vomiting, severe muscle pain (especially after acute illness or dehydration), chest pain, or sudden severe confusion, call 000 or go to your nearest emergency department. Do not wait, and do not message us first.
Frequently asked questions
-
Will I be on this forever?
Not necessarily. For type 2 diabetes, if you genuinely change your eating, movement, weight, and sleep, the dose can sometimes come down — occasionally off entirely. For PCOS, metformin often becomes unnecessary as cycles regulate and insulin resistance improves. For prediabetes, dose-reduction-to-stop is the goal as risk normalises. We do this together with monitoring, not on your own. The exception is established type 2 diabetes with significant duration or complications — there the medicine is doing structural protection beyond a number, and we usually keep it going.
-
Why am I on metformin if I don't have diabetes?
Two common reasons. First — PCOS. Metformin helps with insulin resistance, can support ovulation, and improves the metabolic side of PCOS. The [Cochrane review](https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003053.pub7/full) supports its use, and RACGP accepts it as part of a PCOS plan — though lifestyle changes and (where appropriate) the combined pill remain the first-line considerations for the menstrual side. Second — prediabetes. The [Diabetes Prevention Program (NEJM 2002)](https://doi.org/10.1056/NEJMoa012512) showed metformin reduced progression to type 2 diabetes by about 31% over 2.8 years. Lifestyle change in the same trial reduced it by 58% — so lifestyle wins the comparison, but metformin is a real lever, particularly if BMI is 35 or above or hyperglycaemia is progressing despite genuine effort. Both PCOS and prediabetes use are off-label in Australia, which means the TGA hasn't formally listed them — not that the evidence is missing.
-
Can berberine replace metformin?
Short answer — not for established type 2 diabetes. Berberine 500 mg three times daily activates a similar pathway (AMPK) and has RCT evidence in PCOS, lipids, and glycaemic control. The mechanism is parallel, not identical, and the trial sizes are much smaller. For established T2DM, metformin has decades of outcome data — cardiovascular protection in [UKPDS 34](https://doi.org/10.1016/S0140-6736(98)07037-8) being the headline — that berberine doesn't have. Berberine can complement metformin in some cases (PCOS, lipid issues, insulin resistance pre-diabetes) but it interacts with several medicines via CYP3A4, can cause its own stomach side effects, and is not safe in pregnancy. If you're considering it, that's the conversation we have in the consult — not something to add solo.
-
What's the deal with B12 and metformin?
Metformin reduces B12 absorption in the lower small bowel. Roughly 10-30% of people on long-term metformin develop measurable B12 deficiency — confirmed in the [DPPOS follow-up data (Aroda et al., JCEM 2016)](https://doi.org/10.1210/jc.2015-3754). The standard plan is to check your B12 level annually after the first 12 months on the medicine. If it's low or borderline, oral cyanocobalamin 500-1000 mcg daily is usually enough; if absorption is poor, hydroxocobalamin 1000 mcg IM every 3 months works reliably. The reason this matters beyond a number: B12 deficiency can cause numbness and tingling in the feet that looks identical to diabetic nerve damage. Easy to attribute the symptom to the wrong cause if no-one checks the level.
-
Why does it make my stomach upset?
Metformin shifts how your bowel handles glucose and bile acids, and about one in four people get diarrhoea, nausea, or a metallic taste in the first 2-3 weeks. Two things help: always take it with food (not before, not after — during a meal), and titrate slowly. The standard start is one 500 mg tablet with dinner for the first week, then a second tablet added with breakfast in week two. If symptoms haven't settled by week 3-4, the switch from immediate-release to the modified-release (XR) version mg-for-mg often fixes it — the absorption is smoother and gentler. If XR also doesn't suit, that's worth a conversation; sometimes the answer is a different medicine entirely, sometimes it's a dose pause and a slower restart.
-
Should I stop before my CT scan?
Sometimes yes, sometimes no — it depends on your kidney function and the type of scan. If you're having a CT scan with iodinated contrast (the dye injected through a drip) and your eGFR is below 60, the standard approach is to pause metformin 24-48 hours before the scan and restart 24-48 hours afterwards once kidney function is rechecked. If your eGFR is above 60 and you're well, you usually don't need to stop. MRI contrast (gadolinium) is a different situation — usually no pause needed. The radiology department will often ask the question, but it's safest to tell your GP about any planned scan with contrast so we can confirm the plan together. Same principle applies to major surgery — pause 24-48 hours before, restart when you're eating and drinking normally afterwards.
-
Is it safe in pregnancy?
It can be, in specific situations. Metformin is used off-label in gestational diabetes when insulin isn't the right fit — the [MiG trial (NEJM 2008)](https://doi.org/10.1056/NEJMoa0707193) showed it's non-inferior to insulin in many cases, though about 46% of women in the trial still needed supplemental insulin. RANZCOG and ADIPS accept it as a reasonable option for selected cases, shared between the GP and the obstetric team. Long-term offspring follow-up data is still evolving — which is a real and honest gap, not a hidden one. If you're planning pregnancy or have just found out, message me — we plan the medicine question case-by-case with your obstetric team, not on the page.
-
What about metformin for longevity?
There is a real research question here — the TAME trial (Targeting Aging with Metformin) is ongoing and looking at metformin in healthy older adults to see if it slows ageing-related disease. The honest answer right now: there's no basis to recommend metformin to a healthy adult for longevity, and I don't prescribe it for that reason. The biological-plausibility argument is interesting (AMPK activation, mitochondrial signalling) and worth tracking. The clinical evidence isn't there yet. Hold both — interesting research direction, not yet a treatment.
Source quality
Sources grouped by evidence tier. AU primary tier first; international where AU is silent or lagging; named-author reconstruction where guidelines have not yet caught up. How tiers work.
-
T1 AU primary 9 sources - Therapeutic Guidelines (eTG) — Endocrinology: Type 2 diabetes
- Australian Medicines Handbook — Metformin
- RACGP — General practice management of type 2 diabetes (2024-26 edition)
- RACGP — Red Book preventive activities (PCOS module)
- NPS MedicineWise — Metformin
- Diabetes Australia — Type 2 diabetes medications
- HealthDirect — Metformin
- ADIPS / RANZCOG — Gestational diabetes consensus
- PBS Schedule — metformin listings
-
T2 International primary 5 sources -
T3 Named-author reconstruction 5 sources - UKPDS 34 — Intensive blood-glucose control with metformin (Lancet 1998)
- Diabetes Prevention Program — Reduction in T2DM incidence (NEJM 2002)
- MiG trial — Metformin vs insulin for gestational diabetes (NEJM 2008)
- Aroda et al. — Metformin and B12 deficiency in DPPOS (JCEM 2016)
- Inzucchi et al. — Metformin in T2DM and kidney disease (JAMA 2014)